Literature DB >> 34790625

Rare Association Between Idiopathic Multicentric Castleman Disease, Nephrotic Syndrome and Polyneuropathy in an Immunocompetent Patient.

Luís Landeiro1, Ana Carolina Freitas2, Margarida Proença1, José Cabeçadas3, Albertina Nunes2, Alexandra Bayão Horta1.   

Abstract

Multicentric Castleman disease (MCD) represents a group of poorly understood lymphoproliferative disorders related to proinflammatory hypercytokinaemia. In immunocompetent patients the aetiology is still unknown, hence the designation of idiopathic MCD (iMCD). To successfully diagnose iMCD, diagnostic criteria must be fulfilled and a large array of alternative diagnoses excluded. Peripheral neuropathy and nephropathy are relatively common findings in cases associated with POEMS syndrome, but very rarely reported in iMCD. We present the case of a 64-year-old man with iMCD (HIV- and HHV-8-negative) with nephrotic syndrome and severe motor polyneuropathy. Alternative diagnoses were excluded. The patient was treated with intravenous glucocorticoid followed by rituximab. Complete clinical and laboratory remission was achieved and maintained at the 2-year follow-up. LEARNING POINTS: iMCD is a lymphoproliferative disease in immunocompetent patients with no known cause.To diagnose iMCD major and minor criteria must be fulfilled, and alternative diagnoses must be excluded.Nephrotic syndrome and motor polyneuropathy are rare in iMCD and all alternative diagnoses must be excluded before relating all of these. © EFIM 2021.

Entities:  

Keywords:  Multicentric Castleman; nephrotic syndrome; polyneuropathy

Year:  2021        PMID: 34790625      PMCID: PMC8592654          DOI: 10.12890/2021_002831

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  10 in total

1.  A rare association of Castleman's disease and nephrotic syndrome.

Authors:  I Tazi; M Rachid; A Quessar; S Benchekroun
Journal:  Saudi J Kidney Dis Transpl       Date:  2011-01

2.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Thomas S Uldrick; Adam Bagg; Dale Frank; David Wu; Gordan Srkalovic; David Simpson; Amy Y Liu; David Menke; Shanmuganathan Chandrakasan; Mary Jo Lechowicz; Raymond S M Wong; Sheila Pierson; Michele Paessler; Jean-François Rossi; Makoto Ide; Jason Ruth; Michael Croglio; Alexander Suarez; Vera Krymskaya; Amy Chadburn; Gisele Colleoni; Sunita Nasta; Raj Jayanthan; Christopher S Nabel; Corey Casper; Angela Dispenzieri; Alexander Fosså; Dermot Kelleher; Razelle Kurzrock; Peter Voorhees; Ahmet Dogan; Kazuyuki Yoshizaki; Frits van Rhee; Eric Oksenhendler; Elaine S Jaffe; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

3.  Renal involvement in Castleman disease.

Authors:  Khalil El Karoui; Vincent Vuiblet; Daniel Dion; Hassan Izzedine; Joelle Guitard; Luc Frimat; Michel Delahousse; Philippe Remy; Jean-Jacques Boffa; Evangéline Pillebout; Lionel Galicier; Laure-Hélène Noël; Eric Daugas
Journal:  Nephrol Dial Transplant       Date:  2010-07-23       Impact factor: 5.992

4.  Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.

Authors:  Makoto Ide; Yasunori Kawachi; Yoichiro Izumi; Kanji Kasagi; Tetsuro Ogino
Journal:  Eur J Haematol       Date:  2006-02       Impact factor: 2.997

5.  Clinical spectrum of Castleman disease-associated neuropathy.

Authors:  Elie Naddaf; Angela Dispenzieri; Jay Mandrekar; Michelle L Mauermann
Journal:  Neurology       Date:  2016-11-02       Impact factor: 9.910

Review 6.  The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease.

Authors:  Michelle L Mauermann
Journal:  Hematol Oncol Clin North Am       Date:  2018-02       Impact factor: 3.722

7.  A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis.

Authors:  Toshiro Sugimoto; Jun Ito; Naoko Takeda; Ippei Gasyu; Tsutomu Okazaki; Masayoshi Sakaguchi; Norihisa Osawa; Yuki Tanaka; Kazumasa Oka; Takashi Uzu; Atsunori Kashiwagi
Journal:  Am J Med Sci       Date:  2008-06       Impact factor: 2.378

Review 8.  POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.

Authors:  Angela Dispenzieri
Journal:  Am J Hematol       Date:  2017-08       Impact factor: 10.047

Review 9.  Update and new approaches in the treatment of Castleman disease.

Authors:  Kah-Lok Chan; Stephen Lade; H Miles Prince; Simon J Harrison
Journal:  J Blood Med       Date:  2016-08-03

Review 10.  Idiopathic multicentric Castleman's disease: a systematic literature review.

Authors:  Amy Y Liu; Christopher S Nabel; Brian S Finkelman; Jason R Ruth; Razelle Kurzrock; Frits van Rhee; Vera P Krymskaya; Dermot Kelleher; Arthur H Rubenstein; David C Fajgenbaum
Journal:  Lancet Haematol       Date:  2016-03-17       Impact factor: 18.959

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.